PEAK6 Group’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-18,400
Closed -$262K 4479
2018
Q1
$262K Buy
+18,400
New +$263K ﹤0.01% 3155
2017
Q4
Sell
-8,400
Closed -$150K 4280
2017
Q3
$150K Sell
8,400
-60,300
-88% -$1.24M ﹤0.01% 3513
2017
Q2
$1.74M Buy
+68,700
New +$1.65M 0.01% 1468

Other funds holding EVH

PEAK6 Group's EVH Position: Q2 2018 in Review

PEAK6 Group reduced its Evolent Health (EVH) stake by 27% in Q2 2018, selling an estimated $110K and leaving 15,903 shares worth $335K. The position accounts for ﹤0.01% of the portfolio, ranked #2920.

PEAK6 Group first reported a position in EVH in Q1 2017 and has held it in 5 quarters since. The position peaked at $1.16M in Q2 2017. 178 funds tracked by Wall St. Rank hold EVH as of Q2 2018.

  • PEAK6 Group held 15,903 shares of Evolent Health worth $335K as of Q2 2018.
  • PEAK6 Group sold 5,787 Evolent Health shares in Q2 2018, an estimated $110K.
  • Evolent Health made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #2920 holding.
  • PEAK6 Group first reported a position in Evolent Health in Q1 2017 and has held it in 5 quarters since.
  • PEAK6 Group's Evolent Health position peaked at $1.16M in Q2 2017.
  • 178 funds tracked by Wall St. Rank held Evolent Health as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.